Phospho-GJA1 (S265) Antibody

What is GJA1/Connexin 43 and why is the phosphorylation at Ser265 significant?

GJA1 (Gap Junction Alpha-1 Protein), also known as Connexin 43 or Cx43, is a 43 kDa gap junction protein that forms connexons, which are transmembrane channels allowing the diffusion of low molecular weight materials between adjacent cells. Phosphorylation of Cx43 regulates multiple aspects of gap junction function, including assembly, gating, and degradation .

The Ser265 phosphorylation site is particularly significant as it represents one of the 21 serine residues in the carboxy terminus of Cx43 that can be phosphorylated by various kinases. Phosphorylation at this specific site has been implicated in regulating gap junctional communication and protein trafficking. Understanding the phosphorylation state of Ser265 provides insight into how cells modulate intercellular communication in response to various physiological and pathological conditions .

What experimental applications are suitable for Phospho-GJA1 (S265) antibodies?

Phospho-GJA1 (S265) antibodies have been validated for multiple experimental applications, including:

• Western blotting (WB): Detecting phosphorylated Cx43 in cell or tissue lysates (recommended dilutions typically 1:500-1:2000)

• Enzyme-Linked Immunosorbent Assay (ELISA): High sensitivity detection (recommended dilutions typically 1:2000-1:10000)

• Immunohistochemistry (IHC): For some antibodies, though this depends on the specific product

For optimal results, researchers should validate the antibody in their specific experimental system and adjust dilutions accordingly. The specific reactivity and applications may vary between different manufacturers' antibodies targeting the same phosphorylation site .

What are the essential controls when using Phospho-GJA1 (S265) antibodies?

When using phospho-specific antibodies like Phospho-GJA1 (S265), the following controls are essential:

• Phosphatase treatment control: Treatment with lambda phosphatase to demonstrate phospho-specificity. This should eliminate or significantly reduce the signal from a true phospho-specific antibody, as demonstrated in Western blot analyses of rat hippocampal lysates with phospho-Connexin 43 antibodies .

• Phosphorylation induction: Using treatments known to induce Cx43 phosphorylation, such as TPA (12-O-tetradecanoylphorbol-13-acetate) for PKC-mediated phosphorylation sites .

• Phospho-blocking peptide: Using the synthesized phosphopeptide used as the immunogen to compete with binding to phosphorylated protein. This should abolish the signal if the antibody is specific .

• Non-phosphorylated control samples: Including samples where the phosphorylation site is known to be unphosphorylated or samples from knockout/knockdown models.

• Multiple antibody validation: Using multiple antibodies targeting different epitopes of the same protein to confirm results .

How can I verify the specificity of a Phospho-GJA1 (S265) antibody?

Verifying antibody specificity is crucial for phospho-specific antibodies. Several approaches can be used:

• Phospho-ELISA: Compare antibody binding to phosphorylated versus non-phosphorylated peptides. A specific phospho-antibody should show significantly higher binding to the phosphorylated peptide .

• Western blot with phosphatase treatment: Treat half of your sample with lambda phosphatase before Western blotting. A specific phospho-antibody signal should be abolished or significantly reduced in the phosphatase-treated sample .

• Mutagenesis studies: Express wild-type Cx43 and S265A mutant (which cannot be phosphorylated at this site) in cells and compare antibody reactivity.

• Kinase activation/inhibition: Treat cells with specific kinase activators or inhibitors known to affect S265 phosphorylation and assess changes in antibody reactivity.

• Mass spectrometry validation: For definitive confirmation, use mass spectrometry to verify the phosphorylation status of the protein in your samples.

What kinases are responsible for phosphorylating Connexin 43 at Ser265?

While the search results don't specifically identify the kinase responsible for S265 phosphorylation, Connexin 43 is known to be phosphorylated by multiple kinases, including:

• Protein kinase C (PKC)

• Mitogen-activated protein kinase (MAPK)

• Casein kinase 1 (CK1)

• Protein kinase B (PKB/Akt)

• p34 cdc2 kinase

• Src tyrosine kinase

Research suggests that S265 may be phosphorylated in response to specific signaling pathways, potentially including src-mediated pathways, as studies have shown that src activation can lead to phosphorylation at multiple serine residues in Connexin 43 . Further research is needed to definitively identify the specific kinase responsible for S265 phosphorylation.

How does phosphorylation at Ser265 differ functionally from other phosphorylation sites on Connexin 43?

Connexin 43 contains multiple phosphorylation sites that serve different functions:

• S368 phosphorylation (PKC-mediated): Reduces unitary channel conductance, favoring 50pS channels over 100pS channels, and decreases intercellular communication .

• S262 phosphorylation: Linked to increased cellular proliferation through an unknown mechanism .

• S279/282 phosphorylation: Associated with gap junction downregulation, potentially through src-mediated pathways .

• S325/328/330 phosphorylation (CK1-mediated): Associated with protection against ischemia-induced Cx43 gap junction remodeling and reduced susceptibility to ventricular tachyarrhythmias .

• Y247 and Y265 phosphorylation (src-mediated): Involved in downregulation of gap junction communication .

While the specific functional consequences of S265 phosphorylation aren't explicitly detailed in the search results, phosphorylation at this site likely plays a role in regulating gap junction assembly, channel conductance, or protein trafficking, similar to other phosphorylation sites in this region. The proximity of S265 to the Y265 tyrosine phosphorylation site suggests potential interplay between these modifications .

What are the optimal sample preparation methods when detecting phosphorylated Connexin 43?

When preparing samples to detect phosphorylated Connexin 43, consider the following:

• Rapid sample collection and processing: Phosphorylation states can change rapidly, so quick sample collection and immediate processing or flash-freezing are essential.

• Phosphatase inhibitors: Include a comprehensive phosphatase inhibitor cocktail in all lysis buffers to prevent dephosphorylation during sample preparation.

• Lysis buffer composition: Use buffers containing 1-2% SDS or RIPA buffer with phosphatase inhibitors. For membrane proteins like Connexin 43, ensure efficient solubilization.

• Sample handling: Keep samples cold throughout processing to minimize phosphatase activity.

• Tissue-specific considerations: For brain, cardiac, or other tissues where Connexin 43 is abundant, specialized extraction protocols may be necessary to maintain phosphorylation states .

• Protein determination: Use a method compatible with your lysis buffer for accurate protein quantification.

• Storage: Store samples at -80°C with phosphatase inhibitors added. Avoid repeated freeze-thaw cycles that could affect phosphorylation status .

How can I distinguish between different phosphorylation states of Connexin 43 in Western blot analysis?

Connexin 43 appears as multiple bands on Western blots due to different phosphorylation states. To distinguish between these states:

• Use phospho-specific antibodies: Employ antibodies specific to different phosphorylation sites (S255, S262, S265, S368, etc.) in parallel Western blots .

• Migration pattern analysis: Non-phosphorylated Connexin 43 (P0) migrates fastest, while phosphorylated forms (P1, P2) migrate more slowly. The antibody recognizing non-phosphorylated Cx43 predominantly binds to the P0 form .

• Phosphatase treatment: Treat duplicate samples with lambda phosphatase to convert all phosphorylated forms to the non-phosphorylated form, which should result in a single band corresponding to P0 .

• Combined approach: Use both total Cx43 antibodies and phospho-specific antibodies on the same membrane (with appropriate stripping between probing) to identify the relative proportion of phosphorylated versus total protein.

• Molecular weight markers: The approximate molecular weight of Connexin 43 is 43 kDa, with phosphorylated forms migrating slightly higher .

How can phospho-specific antibodies be used to study Connexin 43 in disease models?

Phospho-specific Connexin 43 antibodies are valuable tools for studying disease models, particularly those involving cellular communication disruption:

• Cardiac ischemia models: Studies have shown that ischemia promotes internalization of Connexin 43 gap junctions by modifying phosphorylation status, reducing cell-cell communication. Phospho-specific antibodies can track these changes in real-time .

• Duchenne muscular dystrophy: Research using transgenic mice with the phosphomimetic Cx43-S3E mutation (S325/328/330E) showed attenuated Cx43 gap junction remodeling and reduced arrhythmia vulnerability when crossed with the mdx model of Duchenne muscular dystrophy .

• Cancer models: As Connexin 43 phosphorylation affects cellular proliferation, phospho-specific antibodies can help understand how changes in phosphorylation contribute to cancer progression.

• Cell cycle studies: Since Connexin 43 phosphorylation changes throughout the cell cycle, phospho-specific antibodies can be used to correlate communication changes with cell cycle progression .

• Brain injury and neuropathology: Phosphorylation-specific antibodies can track changes in Connexin 43 regulation following trauma or in neurodegenerative diseases .

What are the challenges in interpreting results from multiple phosphorylation sites on Connexin 43?

Interpreting results from studies examining multiple phosphorylation sites on Connexin 43 presents several challenges:

• Interdependence of phosphorylation events: Phosphorylation at one site may influence phosphorylation at other sites. For example, src activation leads not only to phosphorylation on Y247 and Y265 but also triggers phosphorylation at S262, S279/282, and S368, while decreasing phosphorylation at S364/365 .

• Temporal dynamics: Different sites may be phosphorylated with different kinetics following stimulation, making time-course studies essential.

• Spatial considerations: Phosphorylation may occur differently in gap junction plaques versus newly synthesized or internalized protein pools.

• Functional redundancy: Multiple phosphorylation events may have similar functional outcomes, complicating the interpretation of single-site studies.

• Technical limitations: Antibody cross-reactivity between closely spaced phosphorylation sites can complicate analysis. Validating antibody specificity is crucial, especially for sites like S261 and S265 that are relatively close .

• Context-dependency: The functional consequence of phosphorylation at a specific site may depend on the cell type, physiological state, or disease context.

To address these challenges, researchers should consider using multiple approaches, including site-directed mutagenesis, mass spectrometry, and combinations of phospho-specific antibodies to build a comprehensive understanding of Connexin 43 regulation .

How can CRISPR/Cas9 genome editing be used with phospho-specific antibodies to study Connexin 43 function?

CRISPR/Cas9 genome editing offers powerful approaches to studying Connexin 43 phosphorylation when combined with phospho-specific antibodies:

• Phosphorylation site mutation: CRISPR/Cas9 can be used to create precise mutations at specific phosphorylation sites (e.g., S265A to prevent phosphorylation or S265D/E for phosphomimetic mutations). The ESI-17 human embryonic stem cell line has been successfully edited using CRISPR/Cas9 to modify Connexin 43 phosphorylation sites .

• Knock-in of tagged Connexin 43: Creating endogenously tagged Cx43 allows for easier immunoprecipitation and phosphorylation analysis under physiological expression levels.

• Kinase knockout studies: CRISPR-mediated knockout of specific kinases suspected to phosphorylate S265, followed by phospho-specific antibody analysis, can help identify the responsible kinase.

• Pathway component editing: Modifying upstream signaling components and measuring changes in S265 phosphorylation can help map the relevant signaling pathway.

• Cell-type specific studies: Using conditional CRISPR systems to study phosphorylation in specific cell types where Connexin 43 has distinct functions.

When implementing these approaches, researchers should validate genomic modifications by sequencing and confirm protein expression levels, as these could affect phosphorylation patterns independent of the specific site modification .

What are the latest techniques for simultaneously detecting multiple phosphorylation sites on Connexin 43?

Recent advances allow for more comprehensive analysis of multiple phosphorylation sites on Connexin 43:

• Multiplexed Western blotting: Using different fluorophore-conjugated secondary antibodies to simultaneously detect multiple phosphorylation sites on the same membrane.

• Mass spectrometry approaches:

  • Phosphoproteomics with enrichment techniques

  • Parallel reaction monitoring (PRM) for targeted quantification of specific phosphopeptides

  • AQUA peptide-based absolute quantification of phosphorylation stoichiometry

• Proximity ligation assay (PLA): Detecting specific phosphorylation events in situ with subcellular resolution.

• Phos-tag SDS-PAGE: This technique enhances the separation of phosphorylated protein species, allowing better resolution of differently phosphorylated forms of Connexin 43.

• Microfluidic immunoassays: Allowing for quantitative analysis of multiple phosphorylation sites from limited sample amounts.

• Phospho-specific antibody arrays: Custom antibody arrays for simultaneous detection of multiple phosphorylation sites.

• Single-cell phospho-proteomics: Emerging techniques enabling the analysis of phosphorylation heterogeneity across individual cells in a population.

These advanced techniques provide researchers with tools to understand the complex interplay between different phosphorylation events on Connexin 43 and their functional consequences in various physiological and pathological contexts .

How do the functions of S265 phosphorylation compare with other serine phosphorylation sites in the C-terminal domain of Connexin 43?

The C-terminal domain of Connexin 43 contains multiple serine phosphorylation sites with distinct functions:

While the specific functional consequences of S265 phosphorylation remain to be fully characterized, its position in the regulatory domain of Connexin 43 suggests it plays an important role in modulating gap junction function, possibly in coordination with other nearby phosphorylation sites .

What methods can be used to quantitatively measure changes in S265 phosphorylation levels in response to physiological stimuli?

To quantitatively measure changes in S265 phosphorylation in response to physiological stimuli, researchers can employ several approaches:

• Quantitative Western blotting:

  • Normalize phospho-S265 signal to total Connexin 43

  • Use fluorescent secondary antibodies for wider linear range

  • Include calibration curves with known quantities of phosphorylated peptides

• ELISA-based methods:

  • Sandwich ELISA using capture antibodies for total Cx43 and detection antibodies for phospho-S265

  • Phospho-ELISA comparing signal ratios between phosphorylated and non-phosphorylated peptides

• Mass spectrometry approaches:

  • Selected/multiple reaction monitoring (SRM/MRM) for targeted quantification

  • SILAC or TMT labeling for relative quantification across conditions

  • Absolute quantification using isotope-labeled standard peptides

• Flow cytometry:

  • For cell-by-cell analysis of phosphorylation status in heterogeneous populations

  • Can be combined with other cellular markers

• Imaging approaches:

  • Quantitative immunofluorescence with phospho-specific antibodies

  • FRET-based biosensors designed to detect specific phosphorylation events

• In-cell Western:

  • Allows for higher throughput analysis of phosphorylation changes

  • Good for time-course studies with multiple conditions